Aspen Aerogels Q2 Revenue Jumps 32% QoQ, Guides Q3 Revenue Up to $80M
ASPN has more than doubled off its 52-week low of $2.3.
Summary
Aspen Aerogels reported Q2 revenue of $49.8M, a 32% sequential increase driven by an 81% QoQ surge in Thermal Barrier revenue to $29.5M. The company guided Q3 revenue to $65-80M with adjusted EBITDA of $7-15M, signaling a sharp recovery from the East Providence incident. European Thermal Barrier outlook was raised to $20-30M for 2026, and a new PyroThin award from Jaguar Land Rover adds long-term visibility. The prior LOI for the Statesboro asset sale expired, but the company is actively marketing the assets. This follows the Q1 10-Q that showed a significant revenue decline and negative EBITDA; the Q2 beat and strong guidance indicate the restart is progressing faster than feared.
At the time of this announcement, ASPN was trading at $5.84 on NYSE in the Manufacturing sector, with a market capitalization of approximately $415.2M. The 52-week trading range was $2.30 to $9.78. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.